InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,071.63
(
0.00%
)
US TECH 100
16,789.20
(
-1.59%
)
Dow Jones
38,460.92
(
0.00%
)
Brent Oil
87.09
(
-0.15%
)
Bitcoin
62,934.56
(
-2.10%
)
CANNF
Cannastat Therapeutics Inc.
Add Alert
Follow
0
CANNF
Cannastat Therapeutics Inc.
Add Alert
Follow
0

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up
Live Updating
profile icon
hermso Free
02/25/10 1:06 PM
Post #2
Last Read
profile icon
Rich Free
02/25/10 10:20 AM
Post #1
Last Read

Cannastat Therapeutics Inc. (CANNF) RSS Feed

Followers
0
Posters
2
Posts (Today)
0
Posts (Total)
2
Created
02/24/10
Type
Free
Moderators
Cannasat is a specialty clinical development pharmaceutical company targeting diseases of the brain. Cannasat has a proprietary formulation technology for cannabinoid drug candidates, which may be used to treat neuropathic pain associated with multiple sclerosis and cancer, as well as for nausea/vomiting and appetite stimulation.
CANNF Latest News
  • No Recent News Available for this company!
More CANNF News
New Post